Project Grant R01CA290559
Award Date
1/15/25
Completion Date
12/31/29
Dollars Obligated
$762K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), aims to assess, optimize, and deliver surgical feedback using artificial intelligence (AI) for benign urological robotic surgeries. The award of $1,192,358, granted on December 1, 2024, will fund a 5-year project conducted by Cedars-Sinai Medical Center. The key products and services to be delivered include: Assessing the current surgical dialogue and feedback...
The National Cancer Institute (NCI) awarded a $680,433 Project Grant under CFDA 93.394 - Cancer Detection and Diagnosis Research to The Regents of the University of California, San Francisco (UCSF) to conduct a multi-year research project titled "Multimodality Spatial Analysis in Prostate Cancer to Improve Prognostic Estimation and Cast Light into the Black Box of Pathology Artificial Intelligence Algorithms." The goal of this research is to apply cutting-edge spatial proteogenomic...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the Sloan-Kettering Institute for Cancer Research provides $700,611 to conduct a randomized controlled trial (RCT) evaluating the use of artificial intelligence (AI) to assist dermatologists in diagnosing melanoma. The project aims to determine the potential benefits and barriers to adopting AI technology, as well as assess its impact on reducing the number of unnecessary...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to Yale University totals $167,500 and will be executed from September 2023 through August 2025. The primary objectives are to: Develop deep neural network-based emulation analysis methods and software to objectively quantify the relative effectiveness of drugs, devices, and treatment procedures on cancer prognosis, especially when randomized clinical trials are not feasible. The...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $245,087 to the University of Delaware from June 1, 2025 to May 31, 2027. The primary objectives are to: Curate a comprehensive dataset of 300 public and 50 Memorial Sloan Kettering MRI scans, annotated with corresponding PIRADS radiology reports, to enable machine-readable extraction of radiologist reasoning processes. Develop a Prostate Vision Language Model...
This federal Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of an AI-powered system to enhance the detection and tracking of metastatic colorectal cancer using computed tomography (CT) imaging. The $718,456 award, with a project period from July 1, 2025 to May 31, 2029, will enable researchers at the...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) totaling $459,867 provides funding to develop and clinically validate natural language processing methods, particularly neural language models, to extract and monitor immune-related adverse events (IRAEs) from electronic health records (EHRs) for cancer patients treated with immune checkpoint inhibitors. The project aims to improve IRAE identification, severity...
This Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $538,553.00 to the University of Miami to conduct longitudinal imaging and liquid biopsy studies to identify markers for prostate cancer radiotherapy outcomes. The goal is to develop a multivariable model that incorporates pre-treatment and longitudinal multiparametric MRI features and circulating tumor cells to guide physicians' decisions on radiation therapy...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $182,236 to New York University School of Medicine to adapt and pilot test an evidence-based sexual health communication skills training intervention for prostate cancer patients. The key products and services to be delivered include: Conducting focus groups with prostate cancer patients and interviews with providers to identify barriers and facilitators to patient-provider communication...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded a $693,156 Project Grant (CFDA 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health) to the Dana-Farber Cancer Institute, Inc. (DFCI) to develop artificial intelligence (AI) algorithms for predicting prognosis and optimizing treatment selection for cutaneous squamous cell carcinoma (CSCC), a highly prevalent form of skin cancer. The project aims to train and validate AI...